StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.3
  1. Startseite
  2. /Verbindung

Miconazol

Miconazole

HCID 4189
Neue Reaktion
Drucken

Daten werden ergänzt – lade die Seite später neu, um den aktuellen Stand zu sehen

GrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
TeilstruktursucheÄhnliche Strukturen suchen

Grundinformationen

CAS
22916-47-8
Standard-SMILES
Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1
InChIKey
BYBLEWFAAKGYCD-UHFFFAOYSA-N
Summenformel
C18H14Cl4N2O
Durchschnittliche Molmasse
416,1 g/mol
Monoisotopische Masse
413,986024

Überblick

1-[2-(2,4-dichlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl]imidazole is a member of the class of imidazoles that is 1-(2,4-dichlorophenyl)-2-(imidazol-1-yl)ethanol in which the hydroxyl hydrogen is replaced by a 2,4-dichlorobenzyl group. It is a dichlorobenzene, a member of imidazoles and an ether.

Namen und Bezeichner

Bevorzugter Name
Miconazole
IUPAC
1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole
Lokaler Name
Miconazol
Englischer Name
Miconazole
Summenformel
C18H14Cl4N2O
Molmasse
416.13

Namen und Synonyme

miconazole22916-47-8Daktarin IVMiconazolMiconazoloMiconazolum1-[2-(2,4-Dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]-1H-imidazoleDaktarinOravig1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole1H-Imidazole, 1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]-DTXSID6023319
Weitere Namen anzeigen
MICONAZOLE BASE1H-Imidazole, 1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]- (9CI)r18134mjr1762R 18134MinostateNSC 170986Miconozole
7NNO0D7S5M1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole1H-Imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl)methoxy)ethyl)-DTXCID803319Imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl)methoxy)ethyl)-NSC170986DermazoleDumicoat

Datenbank-Bezeichner

Eigenschaften

Berechnete StruktureigenschaftenWird ergänzt

XLogP
5,3
Polarare Oberfläche (TPSA)
27,1 Ų
H-Brücken-Donoren
0
H-Brücken-Akzeptoren
2
Frei drehbare Bindungen
6
Schwere Atome
25
Formalladung
0
Komplexität
417

Experimentelle und physikochemische Eigenschaften

Drugs · 2 Einträge

Pharmaceuticals -> Antibiotics

Pharmaceuticals

PesticidesBiocide
LogP · 2 Einträge

6.1

5.81

Solubility7.63e-04 g/L
Human Drugs · 4 Einträge

Breast Feeding; Lactation; Milk, Human; Antifungal Agents; Dermatologic Agents

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Dermatological medicines > Antifungal medicines

Endocrine DisruptorsPotential endocrine disrupting compound
Melting Point159 - 163 °C
Physical DescriptionSolid
Collision Cross Section187.51 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

Sicherheit und Regulatorisches

Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.

GHS-Klassifizierung

GHS Classification · 5 Einträge

This chemical does not meet GHS hazard criteria for 1% (1 of 104) of reports.

Warning

H302 (98.1%): Harmful if swallowed [Warning Acute toxicity, oral]

P264, P270, P273, P301+P317, P330, P391, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 104 reports by companies from 11 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Gefahrenhinweise

Regulatory InformationMiconazole: Does not have an individual approval but may be used as a component in a product covered by a group standard. It is not approved for use as a chemical in its own right.
Other Safety InformationIMAP assessments - 1H-Imidazole, 1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]-: Environment tier I assessment
Hazard Classes and CategoriesAcute Tox. 4 (98.1%)

Toxikologische Informationen

Exposure RoutesTopical
Toxicity Summary · 1 Eintrag

Miconazole interacts with 14-α demethylase, a cytochrome P-450 enzyme necessary to convert lanosterol to ergosterol. As ergosterol is an essential component of the fungal cell membrane, inhibition of its synthesis results in increased cellular permeability causing leakage of cellular contents. Miconazole may also inhibit endogenous respiration, interact with membrane phospholipids, inhibit the transformation of yeasts to mycelial forms, inhibit purine uptake, and impair triglyceride and/or phospholipid biosynthesis.

Chemie und Industrie

Pharmakologische Informationen

ATC Code · 6 Einträge

D01AC02

D - Dermatologicals

S - Sensory organs

G - Genito urinary system and sex hormones

J - Antiinfectives for systemic use

A - Alimentary tract and metabolism

Protein Binding_In vitro_ data suggests that miconazole binds human serum albumin, however, the clinical significance of this observation is unclear.
Pharmacodynamics · 1 Eintrag

Miconazole is an azole antifungal that functions primarily through inhibition of a specific demethylase within the CYP450 complex. As miconazole is typically applied topically and is minimally absorbed into the systemic circulation following application, the majority of patient reactions are limited to hypersensitivity and cases of anaphylaxis. Patients using intravaginal miconazole products are advised not to rely on contraceptives to prevent pregnancy and sexually transmitted infections, as well as not to use tampons concurrently.

Mechanism of Action · 1 Eintrag

Miconazole is an azole antifungal used to treat a variety of conditions, including those caused by _Candida_ overgrowth. Unique among the azoles, miconazole is thought to act through three main mechanisms. The primary mechanism of action is through inhibition of the CYP450 14α-lanosterol demethylase enzyme, which results in altered ergosterol production and impaired cell membrane composition and permeability, which in turn leads to cation, phosphate, and low molecular weight protein leakage. In addition, miconazole inhibits fungal peroxidase and catalase while not affecting NADH oxidase activity, leading to increased production of reactive oxygen species (ROS). Increased intracellular ROS leads to downstream pleiotropic effects and eventual apoptosis. Lastly, likely as a result of lanosterol demethylation inhibition, miconazole causes a rise in intracellular levels of farnesol. This molecule participates in quorum sensing in _Candida_, preventing the transition from yeast to mycelial forms and thereby the formation of biofilms, which are more resistant to antibiotics. In addition, farnesol is an inhibitor of drug efflux ABC transporters, namely _Candida_ CaCdr1p and CaCdr2p, which may additionally contribute to increased effectiveness of azole drugs.

Zugehörige Reaktionen

33
Reaktionsaufzeichnung erstellen
Reaktionsgleichung von HRID 200761
HRID 200761als Edukt
Reaktionsgleichung von HRID 328633
HRID 328633als Edukt
Reaktionsgleichung von HRID 328634
HRID 328634als Edukt
Reaktionsgleichung von HRID 328635
HRID 328635als Edukt
Reaktionsgleichung von HRID 328636
HRID 328636als Edukt
Reaktionsgleichung von HRID 328637
HRID 328637als Edukt
Reaktionsgleichung von HRID 328638
HRID 328638als Edukt
Reaktionsgleichung von HRID 328639
HRID 328639als Edukt
ZurückSeite 1 von 5

Notizen zur Verbindung

Auf dieser SeiteGrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
CAS
22916-47-8
PubChem CID
4189
DTXSID
DTXSID6023319
ChEMBL
CHEMBL91
ChEBI
CHEBI:82892
UNII
7NNO0D7S5M
EC Number
245-324-5
Nikkaji
J11.471E

Physikochemische Eigenschaften

Schmelzpunkt
159 · 159-163C
Siedepunkt
555.1 · 555.1±50.0 °C(Predicted)
Dichte
1.5326 · 1.5326 (rough estimate)
Brechungsindex
1.62 · 1.6200 (estimate)
Flammpunkt
87 ° · 87°(189°F)
storage temp.
Sealed in dry,Room Temperature
Löslichkeit
Very slightly soluble in water, freely soluble in methanol, soluble in ethanol (96 per cent).
Aggregatzustand
Solid
pka
6.91 · pKa 6.91(H2O,t =25) (Uncertain)
Farbe
White to Off-White
Wasserlöslichkeit
Freely soluble in alcohols or acetone. Also soluble in DMF or chloroform. Insoluble in water
Major Application
pharmaceutical (small molecule)
InChI
1S/C18H14Cl4N2O/c19-13-2-1-12(16(21)7-13)10-25-18(9-24-6-5-23-11-24)15-4-3-14(20)8-17(15)22/h1-8,11,18H,9-10H2
InChIKey
BYBLEWFAAKGYCD-UHFFFAOYSA-N
SMILES
Clc1c(ccc(c1)Cl)C(OCc3c(cc(cc3)Cl)Cl)C[n]2cncc2
CAS Datenbank
22916 · 22916-47-8(CAS DataBase Reference)
NIST chemische Informationen
Miconazole(22916-47-8)
EPA chemische Informationen
1 H-Imidazole, · 1H-Imidazole, 1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]- (22916-47-8)
Signs and SymptomsIngestion of the amounts of the components contained in a tube of cream are unlikely to produce overdosage and toxic effects.
Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).
Drug Induced Liver Injury · 5 Einträge

Drug-Induced Liver Injury Severity and Toxicity (DILIst)

miconazole

DILI Negative

Topical

DOI:10.1016/j.drudis.2019.09.022

Effects During Pregnancy and Lactation · 2 Einträge

◉ Summary of Use during Lactation

◈ What is miconazole?

Toxicity DataLD50: 3800 mg/kg (Oral, Mouse) (A308) LD50: 3 gm/kg (Oral, Rat) (A308)
EPA Human Health Benchmarks for Pharmaceuticals · 6 Einträge

Miconazole

1.2

4.9

The recommended dosing schedule for miconazole is the application of one 50 mg buccal tablet to the upper gum region (canine fossa) once daily for 14 consecutive days.

Data used to generate the benchmarks include the following: Lowest Daily Dose (LDD): 50 mg/day, Lowest Therapeutic Dose (LTD): 0.6 mg/kg-day, and Screening Dose: 0.0002 mg/kg-day.

1-Jan-22

Sicherheitsdaten

wgk
3
ridadr
3249
hs_code
2933290000
risk_code
22
hazard_code
Xn
safety_code
22-36
hazard_class
6.1(b)
packing_group
III
Speicherklasse
11 - Combustible Solids
Hazard Classifications
Acute Tox. 4 OralAquatic Chronic 4
Biological Half-LifeMiconazole has a terminal half-life of 24 hours.
Metabolism/MetabolitesMiconazole is metabolized in the liver and does not give rise to any active metabolites.
FDA Pharmacological Classification · 6 Einträge

7NNO0D7S5M

MICONAZOLE

Established Pharmacologic Class [EPC] - Azole Antifungal

Chemical Structure [CS] - Azoles

Miconazole is an Azole Antifungal.

MICONAZOLE

MeSH Pharmacological Classification · 4 Einträge

Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues.

Compounds that specifically inhibit STEROL 14-DEMETHYLASE. A variety of azole-derived ANTIFUNGAL AGENTS act through this mechanism.

Drugs and compounds which inhibit or antagonize the biosynthesis or actions of CYTOCHROME P-450 CYP2C9.

Drugs and compounds which inhibit or antagonize the biosynthesis or actions of CYTOCHROME P-450 CYP3A.

Absorption, Distribution and Excretion · 3 Einträge

Miconazole given to healthy volunteers as a single 50 mg oral tablet produced a mean Cmax of 15.1 ± 16.2 mcg/mL, a mean AUC0-24 of 55.2 ± 35.1 mcg\*h/mL, and a median Tmax of 7 hours (range 2.0-24.1). In these patients measurable plasma concentrations ranged from 0.5 to 0.83 mcg/mL. Topical miconazole is absorbed poorly into the systemic circulation. In pediatric patients aged 1-21 months given multiple topical applications of miconazole ointment for seven days, the plasma miconazole concentration was less than 0.5 ng/mL in 88% of the patients, with the remaining patients having a concentration of 0.57 and 0.58 ng/mL, respectively. Similarly, patients. administered with a vaginal 1200 mg ovule had a mean Cmax of 10.71 ng/mL, mean Tmax of 18.4 hours, and mean AUC0-96 of 477.3 ng\*h/mL.

Miconazole is excreted through both urine and feces; less than 1% of unchanged miconazole is recovered in urine.

A 1200 mg miconazole vaginal suppository resulted in a calculated apparent volume of distribution of 95 546 L while a 100 mg vaginal cream yielded an apparent volume of distribution of 10 911L.

Cellular LocationsCytoplasm

Verwendung und Herstellung

Uses · 2 Einträge

Use (kg; approx.) in Germany (2009): >1000

For topical application in the treatment of tinea pedis (athlete&rsquo;s foot), tinea cruris, and tinea corporis caused by <i>Trichophyton rubrum</i>, <i>Trichophyton mentagrophytes</i>, and <i>Epidermophyton floccosum</i>, in the treatment of cutaneous candidiasis (moniliasis), and in the treatment of tinea versicolor.

Anwendungen · 1 Eintrag

VerwendenAntifungal;Sterol 14-demethylase inhibitor. Miconazole (Monistat-Derm, Micatin, etc.) is a synthetic imidazole antifungal compound that acts by altering cell membrane permeability. It is effective against most dermatophyte species, P. orbiculare, and C. albicans.

Vor- und nachgelagerte Produkte

Vorgelagerte Rohstoffe

2,4'-Dichloracetophenonα,2,4-Trichlortoluol1-(2,4-Dichlorphenyl)-2-(1H-imidazol-1-yl)ethan-1-on(2,4-Dichlorphenyl)oxiranα-(2,4-Dichlorphenyl)-1H-imidazol-1-ethanol2,2',4'-Trichloracetophenon

Nachgelagerte Produkte

SULCONAZOLE